CDSCO Says Injectable Cosmetic Products Not Allowed Under Law

CDSCO cracks down on cosmetic injectables amid safety concerns

In a significant move that could reshape India’s booming cosmetic treatment industry, the Central Drugs Standard Control Organisation (CDSCO) has stated that injectable cosmetic products are not permitted under existing provisions of Indian law unless they receive specific regulatory approval.

The clarification has sent ripples through dermatology clinics, aesthetic centres and medical spas across the country, many of which routinely advertise treatments involving skin brightening injections, anti-ageing boosters, dermal fillers and intravenous cosmetic therapies.

Health officials say the regulator’s position is aimed at curbing the growing use of unapproved injectable products, many of which enter the Indian market through grey channels or are promoted aggressively on social media without adequate scientific scrutiny.

The warning is particularly relevant for urban centres such as Kolkata, Siliguri, Durgapur and Haldia, where cosmetic enhancement procedures have seen a sharp rise over the last few years, driven by social media beauty trends and increasing disposable incomes among younger consumers.

What exactly did CDSCO say?

According to officials familiar with the development, CDSCO clarified that injectable cosmetic products do not fall within legally permitted categories unless approved under the Drugs and Cosmetics Act and relevant medical regulations.

The regulator reportedly observed that many products marketed as “cosmetic injectables” are being administered without proper authorisation, despite claims that they improve skin tone, reduce ageing, boost collagen or enhance facial features.

A senior health ministry official said the concern is not limited to one product category.

“There are multiple injectable preparations being marketed for cosmetic purposes without adequate approval pathways. Patient safety is the primary concern,” the official said.

The clarification is expected to trigger tighter inspections of clinics and distributors handling imported injectable products.

Rise of the cosmetic injection market in India

India’s aesthetic medicine industry has expanded rapidly since the pandemic years. Procedures once associated with celebrities and high-end cosmetic surgery centres are now widely available in neighbourhood skin clinics.

Advertisements for glutathione injections, salmon DNA boosters, mesotherapy treatments, under-eye fillers and IV skin therapies have become common on Instagram, YouTube and local clinic promotions.

Industry estimates suggest India’s cosmetic treatment market is growing at more than 15 per cent annually, fuelled by younger consumers between 20 and 35 years of age.

Many clinics offer lunchtime procedures that promise “instant glow”, “glass skin” or “age reversal” with minimal recovery time.

Doctors, however, say the regulatory framework has struggled to keep pace with the industry’s explosive growth.

Doctors warn against unregulated procedures

Several dermatologists welcomed CDSCO’s clarification, arguing that the sector has become increasingly vulnerable to unsafe practices.

Dr Koushik Lahiri, a Kolkata-based dermatologist, said the market has witnessed a flood of imported products with questionable approval status.

“Patients often assume that if a treatment is available in a clinic, it must be legally approved and medically safe. That is not always true,” he said.

He added that improperly administered injectables can lead to severe allergic reactions, infections, tissue damage and long-term complications.

Medical experts say the biggest risk comes from procedures conducted by untrained practitioners or salons masquerading as aesthetic clinics.

In some cases, injectable treatments are reportedly administered by technicians without emergency medical backup.

Glutathione and whitening injections under scrutiny

Among the products attracting the most attention are glutathione injections, which are widely marketed online as skin-whitening or skin-brightening treatments.

Although glutathione has approved medical uses in certain conditions, experts say its cosmetic application through injections remains controversial.

The Indian Association of Dermatologists, Venereologists and Leprologists has previously cautioned against indiscriminate use of whitening injections, citing insufficient evidence regarding long-term safety.

International regulators have also issued warnings in the past about the misuse of cosmetic injectables and counterfeit fillers.

Impact on clinics and beauty businesses

The CDSCO clarification could significantly affect India’s rapidly expanding beauty and wellness sector.

Clinics may now face stricter documentation checks regarding the sourcing and approval status of products used in cosmetic procedures.

Some aesthetic chains are expected to temporarily suspend certain injectable services until legal clarity emerges.

Industry insiders say distributors dealing in imported Korean and European skin boosters are particularly worried about increased scrutiny.

A Kolkata-based clinic operator said many businesses are awaiting detailed guidelines from regulators.

“There is confusion over which products are classified as drugs, which are medical devices and which can legally be used cosmetically,” the operator said.

Growing demand in Bengal’s urban centres

West Bengal has witnessed a noticeable rise in demand for cosmetic dermatology services over the last five years.

Clinics offering injectable anti-ageing procedures have expanded in Kolkata, New Town, Salt Lake and Siliguri, while smaller cities including Haldia and Kharagpur have also seen growing interest in aesthetic treatments.

Doctors say social media influencers and celebrity beauty standards have played a major role in pushing demand.

Young professionals increasingly seek procedures promising brighter skin, sharper jawlines and reduced signs of ageing.

But consumer awareness about regulatory approval remains low.

Many patients reportedly do not ask whether products being injected into their bodies have CDSCO clearance.

Calls for stronger oversight

Public health experts are now demanding tighter regulation of the cosmetic medicine industry.

Some have urged authorities to create a separate approval framework specifically for aesthetic injectables, similar to systems followed in parts of Europe and the United States.

Consumer rights groups have also called for mandatory disclosure norms requiring clinics to clearly display the approval status of injectable products.

Legal experts say the CDSCO clarification may expose some clinics to potential action if they are found using unapproved products.

What happens next

The Health Ministry is expected to issue further guidance to state drug controllers and enforcement agencies in the coming weeks.

Industry bodies are likely to seek consultations with regulators to clarify compliance requirements.

For consumers, doctors advise caution before undergoing any injectable cosmetic treatment.

Experts recommend checking whether procedures are being performed by qualified dermatologists or plastic surgeons and asking clinics about the regulatory status of products being used.

The CDSCO intervention marks one of the strongest signals yet that India’s fast-growing cosmetic enhancement industry is heading towards tighter oversight — and possibly a major regulatory reset.